Nonsteroidal anti-inflammatory drugs (NSAIDs) demonstratedanti-cancer activity through the inhibition of cyclooxygenase 2 (COX-2)and by inhibiting COX-2-dependent prostaglandin (PG) production. The gene discussed is PTGS2; the disease is cancer.